Biotie Therapies Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Turku Finland (1992)
Status: Acquired by Acorda Therapeutics (2016)

Organization Overview

First Clinical Trial
2008
NCT00595231
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biotie Therapies Corp. | Biotie Therapies Inc.